Roambee Buys Modum for Pharma
Cold Chain Monitoring
June 11, 2021
made its second acquisition, Modum, a European pharma last mile-focused cold
chain monitoring player based in Zurich, Switzerland. This acquisition will
enable Roambee to expand its cold chain visibility offering from end to end,
covering primary, secondary, and the last mile delivery use-cases to firm up its
leadership position for real-time cold chain monitoring solutions.
Roambee's real-time supply chain visibility platform combines firsthand sensor
inputs and non-sensor data to enable the delivery of shipments and assets on
time, in full, and in top condition. 300+ customers around the world, including
one of the largest US-headquartered COVID-19 vaccine-maker, leverage Roambee's
supply chain signals and intelligence to drive logistics automation.
Modum, founded in 2016, offers proven pharma-grade monitoring solutions and has
raised $13.5 million since its inception. Modum's 'plug & play' solutions work
even in the most difficult logistics scenarios requiring high volume and minimal
touch, such as last mile delivery transactions. It's low unit cost of monitoring
and adherence to all pharma quality compliance requirements, enables companies
like Swiss Post with last-mile delivery visibility.
Modum has developed innovative solutions to bring transparency and unmatched
integrity of location and condition data by using methods such as two-factor
authentication to associate wireless loggers with shipments and feed data into
blockchain networks for authenticity.
Modum's CEO Simon Dössegger said, "Joining forces with Roambee was natural for
Modum due to our shared mission to ensure the timely availability of effective,
original products in the medical supply chain. Modum will enhance Roambee's cold
chain footprint with a proven last mile visibility technology to extend the
Roambee product proposition to a unique global end-to-end visibility solution.
When combined with Roambee's strong multimodal shipment monitoring capabilities,
we can offer granular visibility all the way from manufacturing to a patient's
home at scale."
Sharma, CEO of Roambee said, "While most visibility service providers claim to
deliver real time visibility, they rely on carrier data. Insights will never be
as granular, real-time, and accurate as sensor driven insights, which is key to
logistics automation. With Modum, Roambee will enable customers to automate
their logistics through radically simple access to sensor-driven signals,
delivered by our immersive, location-aware platform - not only for pharma, but
also for fresh produce and food/beverages."
Sharma added, "With COVID-19 vaccines shipped world-over at an unprecedented
scale, makers, movers, governments, NGOs, hospitals, and doctors are placing a
high emphasis on the availability, efficacy, and authenticity of vaccines and
medicines to save human lives. Chain of custody integrity and transparency will
enable speed and Good Distribution Practice (GDP). With Modum, we will deliver a
fully pharma-compliant, real-time visibility solution that includes hardware,
cloud software, data, and managed services."
Key executives from Modum will take up leadership positions at Roambee bringing
in Modum's astute pharma domain knowledge and last mile expertise into Roambee's
product strategy, enabling it to dominate the real-time cold chain visibility